HPV Vaccine In-Waiting Glaxo, still struggling to overcome the Avandia diabetes pill controversy and subsequent lost revenue, has been dealt another blow by the FDA. The agency has issued a “complete response letter” to Glaxo for its Cervarix vaccine. It is unclear whether the … [Read more...] about Glaxo’s Cervarix Not Feeling the FDA Love